Trial Profile
A double blind randomised controlled trial assessing the effect of zoledronate on marrow fat in older osteoporotic persons after suffering a minimal trauma fracture
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Fracture; Osteoporosis
- Focus Therapeutic Use
- Acronyms FAT
- 01 Feb 2011 New trial record